Heather Biele is a medical copy editor at Healio, where she supports the gastroenterology and hematology/oncology teams. With a focus on medicine and healthcare, her expertise spans various topics including oncology, palliative care, and digital health innovations. Biele has been featured in Healio, contributing to discussions on health and wellness, alternative medicine, and healthcare technology.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Heather's coverage is heavily data-centric, often citing research and medical findings. She appears to be interested in a wide range of healthcare and scientific topics, including medical research, health conditions, treatment options, public health, and patient care.
Given her focus on citing data extensively in her articles and the diverse nature of the topics she covers within healthcare and scientific fields, Heather would likely respond positively to pitches that offer access to new or significant studies with clear implications for patient care or public health.
It seems that Heather doesn't have a specific geographic focus but rather focuses on global trends in healthcare and scientific research. Therefore, sources with insights into international studies or those at the forefront of groundbreaking medical discoveries may pique her interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Matthew Shinkle
A street-based treatment program could be an effective and supportive way to provide hepatitis C virus care to adults experiencing unsheltered homelessness, results of a qualitative study showed.Findings, published in JAMA Network Open, showed the majority of participants completed treatment and achieved sustained virologic response. Many also reported various psychosocial benefits as a result of
By: Heather Biele, Matthew Shinkle
NASHVILLE, Tenn. — A mailed fecal immunochemical test-based outreach program increased colorectal cancer screening rates by more than 50% among underserved adults in New York City, according to study results.
By: Shenaz Bagha, Heather Biele
NASHVILLE, Tenn. — Assisted reproductive technology, particularly IVF, appears to be effective for women with inflammatory bowel disease, including those with prior IBD-related surgery, according to study results.
By: Heather Biele, Matthew Shinkle
NASHVILLE, Tenn. — Two doses of hepatitis B virus vaccine with CpG adjuvant may not be sufficient for people with HIV who do not respond to an
By: Heather Biele, Robert Stott
NASHVILLE, Tenn. — Individuals with steatotic liver disease who engaged in leisure-time physical activity had a 16% lower risk for all-cause mortality, regardless of fibrosis status, according to a presenter.
By: Heather Biele, Matthew Shinkle
NASHVILLE, Tenn. — Gastroenterologists in rural areas performed 37% more general endoscopies per physician than their urban peers, but 14% fewer
By: Robert Stott, Heather Biele
NASHVILLE, Tenn. — Investigational oral interleukin-23 inhibitor icotrokinra sustained efficacy and favorable tolerability through week 76 in patients
By: Heather Biele, Shenaz Bagha
NASHVILLE, Tenn. — Antidrug antibodies did not appear to negatively affect outcomes in patients with inflammatory bowel disease after initiation of subcutaneous infliximab following a “drug holiday,” according to a presenter.
By: Heather Biele, Shenaz Bagha
NASHVILLE, Tenn. — Tegoprazan demonstrated significant improvements in 24-hour and nighttime heartburn among patients with nonerosive reflux
By: Heather Biele, Matthew Shinkle
The FDA has expanded its approval of Skyrizi to include subcutaneous induction for adults with moderately to severely active Crohn's disease.
